<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR524.html">Part 524
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 524.1600  Nystatin ophthalmic and topical dosage forms.   Sec. 524.1600a  Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Each milliliter of petrolatum base or each gram  of vanishing cream base ointment contains: 100,000 units of nystatin;  neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500  units of thiostrepton; and 1.0 milligram of triamcinolone acetonide.</p><p class="depth0"><em>(b)</em> Sponsors. For petrolatum base ointments see Nos. 000856, 025463,  054771, and 054925 in Sec. 510.600(c) of this chapter. For vanishing  cream base ointments see Nos. 025463, 054771, and 054925.</p><p class="depth0"><em>(c)</em> Conditions of use--</p><p class="depth0"><em>(1)</em> Amount. </p><p class="depth0"><em>(i)</em> For topical dermatological  use: Clean affected areas and remove any encrusted discharge or exudate,  and apply sparingly either ointment in a thin film.</p><p class="depth0"><em>(ii)</em> For otic use: Clean ear canal of impacted cerumen, remove any  foreign bodies such as grass awns and ticks, and instill three to five  drops of petrolatum base ointment. Preliminary use of a local anesthetic  may be advisable.</p><p class="depth0"><em>(iii)</em> For infected anal glands and cystic areas: Drain gland or cyst  and fill with petrolatum base ointment.</p><p class="depth0"><em>(2)</em> Indications for use. </p><p class="depth0"><em>(i)</em> Topically: Use either ointment in dogs  and cats for anti-inflammatory, antipruritic, antifungal, and  antibacterial treatment of superficial bacterial infections, and for  dermatologic disorders characterized by inflammation and dry or  exudative dermatitis, particularly associated with bacterial or candidal  (Candida albicans) infections.</p><p class="depth0"><em>(ii)</em> Otitis, cysts, and anal gland infections: Use petrolatum base  ointment in dogs and cats for the treatment of acute and chronic otitis  and interdigital cysts, and in dogs for anal gland infections.</p><p class="depth0"><em>(3)</em> Limitations. Federal law restricts this drug to use by or on the  order of a licensed veterinarian.  [40 FR 13873, Mar. 27, 1975, as amended at 43 FR 29770, July 11, 1978;  50 FR 41490, Oct. 11, 1985; 53 FR 39257, Oct. 6, 1988; 54 FR 5431, Feb.  3, 1989; 54 FR 48090, Nov. 21, 1989; 56 FR 50653, Oct. 8, 1991; 60 FR  55660, Nov. 2, 1995; 61 FR 63712, Dec. 2, 1996; 64 FR 42831, Aug. 6,  1999; 67 FR 67521, Nov. 6, 2002; 68 FR 55201, Sept. 23, 2003; 70 FR  50183, Aug. 26, 2005; 71 FR 13542, Mar. 16, 2006; 79 FR 10972, Feb. 27,  2014]    Sec. 524.1600b  Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.</p><p class="depth0"><em>(a)</em> Specifications. Each cubic centimeter of ointment contains:  100,000 units of nystatin, neomycin sulfate equivalent to 2.5 milligrams  of neomycin base, 2,500 units of thiostrepton, and 1.0 milligram of  triamcinolone acetonide.</p><p class="depth0"><em>(b)</em> Sponsor. See No. 053501 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Conditions of use--</p><p class="depth0"><em>(1)</em> Dogs and cats--</p><p class="depth0"><em>(i)</em> Amount. Apply 1 drop  of ointment to the affected eye(s) 2 or 3 times daily. Treatment may be  continued for up to 2 weeks if necessary.</p><p class="depth0"><em>(ii)</em> Indications for use. For use as an anti-inflammatory,  antipruritic, antifungal (Candida albicans), and antibacterial ointment  for local therapy in keratitis and conjunctivitis.</p><p class="depth0"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on  the order of a licensed veterinarian.</p><p class="depth0"><em>(2)</em> Cattle--</p><p class="depth0"><em>(i)</em> Amount. Apply small line of ointment to the affected  eye(s) once daily. Treatment may be continued for up to 2 weeks if  necessary.</p><p class="depth0"><em>(ii)</em> Indications for use. For infectious kerato-conjunctivitis  (pinkeye).</p><p class="depth0"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on  the order of a licensed veterinarian.  [40 FR 13873, Mar. 27, 1975, as amended at 50 FR 41490, Oct. 11, 1985;  79 FR 10972, Feb. 27, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
